Market Overview

Collins Stewart: Incyte's Jakafi Knocks 4Q Sales Out of the Park

Share:

In a research report published earlier today by Collins Stewart, Incyte Corporation's (NASDAQ: INCY) 4Q11 total revenue of $28.9M was above consensus of $25.7M and CSe of $26.8M.

Collins Stewart attributed much of the success to Jakafi: “Gross Jakafi revenue shipped to patients (INCY uses the sell-through method for revenue recognition) was $2.3M ($0.3M in gross-to-net adjustments) while gross revenue from Jakafi sent to specialty pharmacies was $4.9M (resulting in $2.6M in gross deferred revenue and $2.3M net). INCY also provided FY12 financial guidance, expecting amortization revenue of $67M (excludes Jakafi revenue and potential milestones), R&D expense of $215M-$225M (includes $25M-$28M in stock-based comp), SG&A expense of $82M-$88M (including stock-based comp of $13M-$15M) and interest expense of ~$46M (includes non-cash expense of ~$27M related to amortization of the 4.75% Convertible Note). We expect INCY shares to trade higher on today's Jakafi sales numbers and a positive launch outlook.”

Collins Stewart reiterates its Buy rating and $22 PT on Incyte, which closed yesterday at $18.27.

 

Related Articles (INCY)

View Comments and Join the Discussion!

Posted-In: Collins StewartAnalyst Color Reiteration Analyst Ratings

Latest Ratings

StockFirmActionPT
JNJCantor FitzgeraldMaintains200.0
PCTYJMP SecuritiesMaintains220.0
ADIBarclaysMaintains170.0
AMATBarclaysMaintains115.0
KMBRBC CapitalMaintains147.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com